[Pharmacologic treatment of diabetes].
De Montigny
Pascale
P
Centre de jour pour diabétiques du Centre hospitalier Universitaire de Québec, Hôpital CHUL.
Clerc
Carole
C
Descarpentries
Clotilde
C
D001549:Benzamides / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D016903:Drug Monitoring; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D018579:Patient Selection; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use
D001549:Benzamides; D001645:Biguanides; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; C030516:meglitinide